KMT2C and KMT2D amplify GRHL2-driven enhancer activation

This study establishes a tamoxifen-gated system in embryonic stem cells to demonstrate that while the pioneer transcription factor GRHL2 can bind target sites independently, the histone mono-methyltransferases KMT2C and KMT2D function as crucial co-activators that amplify enhancer activation and transcriptional output.

The Gist

Imagine your cell's DNA as a massive, dusty library containing the instructions for building every part of your body. Most of the time, the books (genes) are locked away in the dark, and the lights are off. To turn a specific book on and read it, you need a Librarian (a transcription factor) to find the book, open the door, and flip on the light switch.

In this story, the Librarian is a protein called GRHL2. Its job is to turn on specific genes that help stem cells transform into new types of cells (like skin or organ cells).

However, a Librarian can't just flip a switch by itself. It needs a Crew to help it do the heavy lifting. In this paper, the authors discovered that the most important members of this crew are two workers named KMT2C and KMT2D.

Here is the simple breakdown of what the scientists found:

1. The Problem: Studying the "Switch" is Hard

Usually, when scientists try to study how a cell changes, it's like watching a slow-motion movie where everything happens at once. Genes turn on and off in a messy, overlapping way, making it hard to see who is doing what.

The Solution: The scientists built a "remote control" for the Librarian (GRHL2). They created a special version of GRHL2 that stays locked in the cell's basement (the cytoplasm) until they add a chemical key called Tamoxifen.

• No Tamoxifen: The Librarian is locked away.
• Add Tamoxifen: The lock opens, and the Librarian instantly rushes to the DNA library to start working.
  This allowed the scientists to hit "pause" and "play" on the process, watching exactly what happens in the first few hours.

2. The Discovery: The Librarian vs. The Crew

The scientists wanted to know: Does the Librarian (GRHL2) need the Crew (KMT2C/D) to do its job?

• Finding the Book (Binding): They found that the Librarian is very strong. Even if the Crew is missing, the Librarian can still find the right books and stand right in front of them. The Librarian doesn't need the Crew to find the door.
• Turning on the Lights (Activation): This is where the Crew is essential.
  • With the Crew: When the Librarian arrives, the Crew (KMT2C/D) immediately starts painting the area with "Active" markers (chemical tags like H3K4me1 and H3K27ac). They also call in the electrician (P300) to flip the switch. The lights turn on bright, and the genes start working loudly.
  • Without the Crew: If the scientists removed the Crew, the Librarian still stood in front of the books, but the lights were very dim. The "Active" markers were barely there. The genes did turn on, but they were whispering instead of shouting.

3. The Big Analogy: The Amplifier

The authors realized that KMT2C and KMT2D aren't the only way to turn on a gene, but they are the Volume Amplifiers.

Think of GRHL2 as a singer trying to perform in a stadium.

• GRHL2 alone: The singer can get on stage and sing a little bit. The audience can hear a faint whisper.
• GRHL2 + KMT2C/D: The singer plugs into a massive sound system. The voice becomes loud, clear, and powerful.

Without the sound system (KMT2C/D), the song still happens, but it's weak. With the sound system, the song is a hit.

4. Why This Matters

This discovery changes how we understand cell development and disease.

• Development: When a stem cell decides to become a skin cell, it needs a massive, loud signal to make that change. KMT2C and KMT2D provide that volume boost. Without them, the cell might get confused or fail to change properly.
• Disease: Many cancers and genetic disorders (like Kabuki Syndrome) are caused by broken KMT2C or KMT2D genes. This paper explains why those diseases happen: the "volume" of the cell's instructions is turned down too low, so the body can't build tissues correctly.

Summary

The scientists built a remote-controlled switch to watch a cell in real-time. They found that the "Librarian" (GRHL2) can find the right genes on its own, but it needs the "Crew" (KMT2C/D) to turn up the volume and make the genes work effectively. The Crew isn't strictly necessary to start the engine, but they are absolutely essential for the car to drive fast.

Technical Summary

1. Problem Statement

The activation of cis-regulatory enhancers is fundamental to cell fate specification, yet studying the mechanistic kinetics of this process is challenging due to the asynchronous and interdependent nature of gene regulatory changes during natural differentiation. Specifically, the role of histone mono-methyltransferases KMT2C and KMT2D (part of the COMPASS-like complex) in the activation of enhancers by pioneer transcription factors (TFs) remains unclear. While a canonical model suggests TFs recruit KMT2C/D to deposit H3K4me1/2, which subsequently recruits P300 for H3K27ac deposition, recent evidence suggests context-dependent variations. The study focuses on GRHL2, a pioneer TF that drives the transition from naive to formative embryonic stem cells (ESCs), to determine if KMT2C/D are essential cofactors or amplifiers of GRHL2-mediated enhancer activation.

2. Methodology

The authors developed a novel, rapid, and conditional system to decouple GRHL2 binding from the slow kinetics of natural differentiation:

• Synthetic GRHL2-ERT System: The authors engineered a GRHL2-ERT fusion protein (GRHL2 fused to a mutated estrogen receptor ligand-binding domain). This construct was integrated into the genome of mouse ESCs via PiggyBac transposon.
  • Induction: In the absence of tamoxifen (Tam), GRHL2-ERT is sequestered in the cytoplasm. Upon Tam administration, the protein rapidly translocates to the nucleus and binds chromatin within 1 hour, allowing for "acute" enhancer activation studies.
• Genetic Backgrounds: The system was introduced into:
  • CKO (Conditional Knockout): $KMT2C^{-/-}; KMT2D^{fl/fl}$ (serving as the control, as KMT2C is low in naive ESCs and KMT2D is the primary driver).
  • dKO (Double Knockout): $KMT2C^{-/-}; KMT2D^{-/-}$ (generated by Cre-ERT mediated recombination).
• Experimental Workflow:
  • Cells were treated with Tam for short durations (0–16 hours) to avoid secondary effects of KMT2D loss during the experiment.
  • CUT&Tag/CUT&RUN: Used to profile GRHL2 binding (via HA tag), histone modifications (H3K4me1, H3K4me2, H3K4me3, H3K27ac), and co-factor recruitment (P300, KMT2C/D).
  • RNA-seq: Performed to assess transcriptional output of GRHL2 targets.
  • qRT-PCR: Validated binding and transcription kinetics (using intron:exon and exon:exon primers to distinguish nascent vs. mature RNA).
  • Differentiation Model: Parallel experiments were conducted using natural naive-to-formative differentiation to validate findings in a physiological context.

3. Key Contributions

• Development of an Acute Inducible System: The creation of the GRHL2-ERT system allows for the dissection of pioneer TF kinetics and enzymatic dependencies with high temporal resolution (minutes to hours), overcoming the limitations of traditional doxycycline-inducible systems which suffer from transcriptional ramp-up delays.
• Redefining the Role of KMT2C/D: The study challenges the binary view of KMT2C/D as strictly essential intermediates. Instead, it establishes them as critical amplifiers of pioneer TF activity.
• Mechanistic Hierarchy: The work delineates the order of events: GRHL2 binds chromatin independently of KMT2C/D, but KMT2C/D are required for the robust deposition of active enhancer marks (H3K4me1/2, H3K27ac) and P300 recruitment.

4. Key Results

A. GRHL2 Binding is Independent of KMT2C/D

• Rapid Translocation: GRHL2-ERT enters the nucleus and binds chromatin within 1 hour of Tam treatment.
• Binding Affinity: CUT&Tag analysis showed that GRHL2 binds its 332 known formative target sites with high efficiency in both CKO and dKO backgrounds. The binding signal was highly correlated between the two genotypes (Pearson $r = 0.8$), proving that KMT2C/D are not required for the initial chromatin binding of the pioneer factor.

B. KMT2C/D are Required for Enhancer Mark Deposition (but not absolutely)

• Loss of Marks in dKO: In the absence of KMT2C/D, there was a dramatic reduction in the deposition of H3K4me1, H3K4me2, H3K27ac, and the recruitment of P300 at GRHL2-bound sites.
• Basal Activity: Crucially, these marks were not completely abolished. A significant, albeit reduced, basal level of H3K4me1/2 and H3K27ac acquisition occurred even in dKO cells. This suggests alternative, less efficient mechanisms for enhancer activation exist in the absence of KMT2C/D.

C. Transcriptional Amplification

• Gene Activation: RNA-seq revealed that while GRHL2 induces ~100 genes in CKO cells (e.g., Cldn6, Wnt7b, Epcam), this induction is severely blunted (but not eliminated) in dKO cells.
  • In dKO cells, the fold-change induction was reduced by approximately 60–70% (Slope $\approx$ 0.32x to 0.45x compared to CKO).
  • Only a small subset of genes (e.g., Tmem54, Epcam, Cldn4) retained significant induction in dKO.
• Correlation: There was a strong correlation between the magnitude of histone mark deposition and transcriptional output, reinforcing the "amplifier" model.

D. Validation in Natural Differentiation

• During the natural naive-to-formative transition, endogenous GRHL2 binding was unaffected in dKO cells.
• However, the acquisition of active enhancer marks and the upregulation of GRHL2 target genes were significantly impaired in dKO cells compared to WT/CKO, confirming that the "amplifier" role observed in the acute system holds true in physiological development.

5. Significance and Conclusion

• Mechanistic Insight: The paper proposes a model where pioneer factors like GRHL2 can access closed chromatin independently of KMT2C/D. However, KMT2C/D function as essential amplifiers that recruit P300 and deposit histone marks to drive robust transcriptional activation.
• Alternative Pathways: The persistence of basal activation in dKO cells suggests the existence of compensatory mechanisms (potentially involving other methyltransferases like KMT2A/B or cooperative TFs like GRHL1/3) that can partially bypass the need for KMT2C/D.
• Disease Relevance: Given that KMT2C/D mutations are linked to neurocristopathies (Kleefstra and Kabuki syndromes) and various epithelial cancers, understanding their role as amplifiers of GRHL2 (a tumor suppressor in some contexts) provides new avenues for investigating disease mechanisms and potential therapeutic targets.
• Tool Utility: The GRHL2-ERT system serves as a powerful new tool for dissecting the kinetics of enhancer remodeling and the specific enzymatic dependencies of pioneer factors in stem cell biology.